Relationship between serum zinc and homocysteine in children with nephrotic syndrome

Main Article Content

Welli Hamik
Dany Hilmanto
Sri Endah Rahayuningsih

Abstract

Background In children, most idiopathic nephrotic syndrome (NS) is a minimal lesion, which responds well to steroids. Hyperhomocysteinemia is pathologic and worsens NS by causing chronic inflammation, leading to glomerular sclerosis. Zinc metalloenzymes are involved in homocysteine metabolism.


Objective To assess for a possible relationship between serum zinc and homocysteine in children with NS.


Methods A cross-sectional study was conducted in children with NS aged 1-18 years, who were admitted to Hasan Sadikin Hospital from November 2017 - January 2018. Subjects were selected consecutively. Serum zinc and homocysteine were measured in all subjects. Statistical analysis was done with Pearson’s correlation test. If the distribution was not linear, the analysis was continued with non-linear regression.


Results There were 23 children who met the inclusion criteria. Mean serum homocysteine and zinc levels were 10.37 (SD 4.11) µmol/L and 51.13 (SD 29.69) µg/dL, respectively. Pearson’s correlation analysis showed no linear correlation between them (r coefficient -0.173; P=0.430). However, after adjusting for age and serum albumin level, multiple regression analysis suggested a cubical relationship between serum homocysteine and zinc, using the equation: homocysteine = -4.572 + 0.735 x zinc - 0.0012 x zinc2 + 0.00005 x zinc3 x age (months) (R2 multiple=53.2%; P=0.012). This equation indicates that 53.2% of homocysteine variation was influenced by serum zinc concentration.


Conclusion In childhood NS, homocysteine is not correlated linearly with zinc, but related with cubical model.

Article Details

How to Cite
1.
Hamik W, Hilmanto D, Rahayuningsih S. Relationship between serum zinc and homocysteine in children with nephrotic syndrome. PI [Internet]. 15Apr.2019 [cited 26Jun.2019];59(2). Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2143
Section
Pediatric Nephrology
Received 2019-02-13
Accepted 2019-04-10
Published 2019-04-15

References

1. Andolino TP, Reid-Adam J. Nephrotic syndrome. Pediatr Rev. 2015;36:117-25.
2. Niaudet P, Mattoo TK, Kim MS. Etiology, clinical manifestations, and diagnosis of nephrotic syndrome in children. [cited 2018 October 06]. Available from: https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-nephrotic-syndrome-in-children?search=etiology,%20clinical%20manifestations%20nephrotic%20syndrome&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1.
3. Downie ML, Gallibois C, Parekh RS, Noone DG. Nephrotic syndrome in infants and children: pathophysiology and management. Paediatr Int Child Health. 2017;37:248-58.
4. Li G, Chen Z, Bhat OM, Zhang Q, Abais-Battad JM, Conley SM, et al. NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury. J Lipid Res. 2017;58:1080-90.
5. Yi F, dos Santos EA, Xia M, Chen QZ, Li PL, Li N. Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats. Am J Nephrol. 2007;27:262-8.
6. Tulpar S, Gunduz Z, Sahin U, Hakan Poyrazoglu M, Dursun I, Dusunsel R, et al. Trace elements in children suffering from idiopathic nephrotic syndrome. Eurasian J Med. 2014;46:187-91.
7. Jing M, Rech L, Wu Y, Goltz D, Taylor CG, House JD. Effects of zinc deficiency and zinc supplementation on homocysteine levels and related enzyme expression in rats. J Trace Elem Med Biol. 2015;30:77-82.
8. Haque F, Hanif M, Choudhury TR. Role of zinc in patients with nephrotic syndrome. J Ped Nephrology. 2017;5:1-7.
9. Orimadegun BE, Orimadegun AE, Ademola AD, Agbedana EO. Plasma homocysteine and B vitamins levels in Nigerian children with nephrotic syndrome. Pan Afr Med J. 2014;18:107.
10. Naseri M, Shahri MM, Horri M, Esmaeeli M, Sherbaf FG, Rasouli Z, et al. Mild hyperhomocysteinemia in children and young adults on dialysis: a single center study. J Ped Nephrology. 2015;3:155-64.
11. De Laet C, Wautrecht JC, Brasseur D, Dramaix M, Boeynaems JM, Decuyper J, et al. Plasma hemocysteine concentration in a Belgian school-age population. Am J Clin Nutr. 1999;69:968–72.
12. Zhang C, Boini KM, XIa M, Abais JM, Li X, Liu Q, et al. Activation of nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension. 2012;60:154-62.
13. Kundu S, Tyagi N, Sen U, Tyagi SC. Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic mice. Mol Cell Biochem. 2009;332:215-24.
14. Dwivedi J, Sarkar PD. The study of total antioxidant capacity, homocysteine, lipoprotein (a), total protein and albumin with copper and zinc in nephrotic syndrome. Int J Healthcare Biomed Res. 2014;2:79-86.
15. Bhatt GC, Jain S, Das RR. Zinc supplementation as an adjunct to standard therapy in childhood nephrotic syndrome- a systematic review. World J Clin Pediatr. 2016;5:383-90.
16. Arun S, Bhatnagar S, Menon S, Saini S, Hari P, Bagga A. Efficacy of zinc supplements in reducing relapses in steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2009;24:1583-6.
17. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004;50:3-32.
18. Heidarian E, Amini M, Parham M, Aminorroaya A. Effect of zinc supplementation on serum homocysteine in type 2 diabetic patients with microalbuminuria. Rev Diabet Stud. 2009;6:64-70.
19. Kaul S, Zadeh AA, Shah PK. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. J Am Coll Cardiol. 2006;48:914-23.
20. Pakfetrat M, Shahroodi JR, Zolgadr AA, Larie HA, Nikoo MH, Malekmakan L. Effects of zinc supplement on plasma homocysteine level in end-stage renal disease patients: a double-blind randomized clinical trial. Biol Trace Elem Res. 2013;153:11-5.